NYSE · REZI

Resideo Technologies, Inc.

$35.24 +$0.70 (+2.03%) 1D After hours

Key Metrics

$5.23B
Market cap
P/E · TTM
$7.61B
Revenue · TTM
−$495.00M
Net income
EPS · TTM $-3.34
Dividend yield
Free cash flow −$1.34B
Beta · 1Y 2.00
EBITDA · TTM
Gross margin 29.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 19
    From its Apr 30 high, the share price fell 35%.

    Peak close $41.37 on Apr 30; trough close $26.79 on May 19. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -35%
  • May 13
    The stock moved -17.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 13
  • Feb 25
    The stock moved +14.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$5.23B
Enterprise value$7.98B
Shares outstanding151.4M
52-wk range$24.34 – $45.29
Avg volume · 20D961.2K
Net cash −$2.75B
Book value / share$19.74
IndustryWholesale-Hardware
ExchangeNYSE
About Resideo Technologies, Inc.
IPO dateOct 15, 2018
Employees14800

Resideo Technologies Inc manufactures, develops, and distributes sensing and control products and solutions for residential and commercial markets.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.69
P/FCF
EV/EBITDA
EV/Sales1.05
Graham №

Profitability

Gross 29.4%
Operating -5.5%
Net -6.5%
FCF -17.6%
ROE / ROIC -15.9% · -8.7%

Financial Health

Current ratio2.07
Quick ratio1.19
Debt / equity1.09
Debt / EBITDA
Net cash −$2.75B
Working capital$1.64B

Cash Flow · TTM

Operating CF −$1.22B
Capex −$121.00M
Free cash flow −$1.34B
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

1.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-04-04 · computed by TickerWolf from SEC filings